Gene · 406900
Papers4,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers. | Int J Mol Sci | 2023 | 37895131 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Post-Traumatic Epileptogenesis: A Systematic Review. | Int J Mol Sci | 2023 | 37895044 | PubTator, text mining | PubMed |
| Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death? | Biomedicines | 2023 | 37893166 | PubTator, text mining | PubMed |
| In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer. | Biomedicines | 2023 | 37893081 | PubTator, text mining | PubMed |
| Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37878007 | PubTator, text mining | PubMed |
| Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach. | J Transl Med | 2023 | 37864227 | PubTator, text mining | PubMed |
| The role of miRNAs in Behçet's disease. | Front Immunol | 2023 | 37860009 | PubTator, text mining | PubMed |
| Vascular calcification: from the perspective of crosstalk. | Mol Biomed | 2023 | 37851172 | PubTator, text mining | PubMed |
| The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens. | Technol Cancer Res Treat | 2023 | 37849311 | PubTator, text mining | PubMed |
| Epigenetic Biomarkers of Metabolic Responses to Lifestyle Interventions. | Nutrients | 2023 | 37836535 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis Confirms the Diagnostic Value of Nourin-Dependent miR-137 and miR-106b in Unstable Angina Patients. | Int J Mol Sci | 2023 | 37834231 | PubTator, text mining | PubMed |
| Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data. | Int J Mol Sci | 2023 | 37833875 | PubTator, text mining | PubMed |
| The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases. | Ageing Res Rev | 2023 | 37832609 | PubTator, text mining | PubMed |
| High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation. | Front Oncol | 2023 | 37829335 | PubTator, text mining | PubMed |
| ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer. | Database (Oxford) | 2023 | 37815872 | PubTator, text mining | PubMed |
| [Effects of microRNA-106b on migration and invasion of human malignant pleural mesothelioma cell NCI-H2452]. | Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi | 2023 | 37805422 | PubTator, text mining | PubMed |
| Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients. | Curr Cardiol Rep | 2023 | 37796395 | PubTator, text mining | PubMed |
| The miRNA transcriptome of cerebrospinal fluid in preterm infants reveals the signaling pathways that promote reactive gliosis following cerebral hemorrhage. | Front Mol Neurosci | 2023 | 37790884 | PubTator, text mining | PubMed |
| Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway. | Biomark Res | 2023 | 37784183 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406900/papers?page=8